What FDA-Registered Means, and What It Does Not

The short answer

Registration is real. A pharmacy or facility that says it is registered with FDA is usually telling the truth, and the status can often be confirmed.

Registration is also not approval, not endorsement, and not verification. FDA says this in more than one place and in unusually direct language, because the confusion is common and predates compounded GLP-1s by decades.

The phrase is effective in marketing precisely because it borrows the shape of approval while making a much smaller claim. Knowing the smaller claim is the whole of the skill here.

What registration actually is

Owners and operators of establishments engaged in the manufacture, preparation, propagation, compounding or processing of drugs register those establishments with FDA and list the drugs they make there. Listing information is updated twice each year, in June and December, with notice to FDA if it has changed.

For an outsourcing facility, FDA describes what the registration date on its public table represents, and the description is worth reading slowly. The initial date of registration is the date FDA determined that the initial registration information submitted for the facility was complete, and the establishment fee was paid in full. The most recent registration date reflects the same two things for the current fiscal year.

So the determination behind a registration date is that a form was complete and a fee was paid. That is an administrative finding, and it is the finding the date records.

Registration under section 503B is also elective. FDA's wording describes a facility that elects to continue to be registered, and one that elects to register or re-register and must pay an annual establishment fee. A facility that stops electing is removed from the list, which is a business decision rather than a verdict on it.

What FDA says registration does not denote

The agency's statement on its drug registration and listing system is short and leaves little room. Registering an establishment and listing drugs with FDA does not indicate the products are approved, or that FDA has verified the information provided.

Read the second half of that sentence again, because it is the part that usually gets lost. It is not only that approval has not happened. It is that the submitted information itself has not been checked.

FDA puts it more broadly elsewhere. Mere registration of an establishment, or listing of a drug or device, does not denote approval of the establishment, the drug or device, or other drugs or devices of the establishment, nor does it mean that a product may be legally marketed.

That last clause is the strongest one in the whole area. Registration does not even establish that a product may lawfully be sold, which is a lower bar than approval and still not cleared by registering.

The same logic applies to a company's other products. Registration attaches to an establishment; it does not travel to everything the establishment makes.

Three things FDA says it does not approve

It helps to see the phrase in its family, because compounding sits inside a much larger pattern of things people assume are approved.

FDA does not approve health care providers, including physician offices or laboratories. The agency has authority to inspect regulated facilities to verify compliance with legal requirements that can affect product safety or quality, but inspection is not approval.

FDA does not approve manufacturing facilities independently. Such facilities are often inspected as part of a product application for products that require premarket approval, and are frequently required to register, but the facility itself is not separately approved.

FDA does not approve compounded drugs. The agency states that compounded drugs are not FDA approved, that by statute compounders do not need to prove to FDA that their products meet the same standards drug manufacturers must meet, and that FDA therefore does not conduct premarket review of compounded drugs to evaluate their safety, effectiveness or quality.

Set those three together and the marketing phrase resolves. A registered establishment, holding a license, making an unapproved drug, is an entirely ordinary and lawful situation. It is also exactly what a compounded GLP-1 is, and none of the three facts implies the others.

Registered is not the same as inspected

There is a second gap, and it is easy to see on FDA's own table.

Once an outsourcing facility registers, it is added to the list of facilities FDA intends to inspect on a risk-based schedule. The agency plans to inspect within a reasonable period following initial registration, once it is confirmed the facility has begun drug production and distribution. Timing is affected by the number of registrants, other inspection priorities and the facility's operational status.

The table reflects that honestly. Rather than leaving a blank, it shows a facility that has not been inspected as not yet inspected, with the inspection status columns beside it reading N/A. A facility can therefore be genuinely registered, currently listed, and never visited.

That is not an accusation about any facility. It is a description of a queue. But it does mean that registered, on its own, tells you nothing about whether anyone from FDA has walked through the building.

The self-reported part

One column on the same table records whether a facility intends to compound sterile drugs from bulk substances, and it is a detail worth knowing the provenance of.

FDA states that the information in that column was provided by the registered outsourcing facility at the time of registration and has not been verified by FDA, and that N/A means the facility has not provided the information.

This is the registration principle made concrete. The register is largely a record of what establishments have told FDA, maintained so the agency can find them, and the agency says as much rather than implying otherwise.

Why registration is still worth something

None of this makes registration meaningless, and it would be a mistake to leave with that impression.

FDA describes complete, accurate and up-to-date establishment registration and drug listing information as essential to promote patient safety, and lists what it relies on that information for: inspections, postmarket surveillance, recalls, supply chain resiliency and counterterrorism, among other programs.

That is a real function. Registration is what makes a facility findable when something goes wrong, which is the same reason the earlier requirement that a compounder's bulk substances come from a registered establishment exists at all. A supply chain of registered entities is one that can be traced.

Registration is infrastructure, in other words, not a grade. It answers where and who, not how good.

Reading the phrase on a page

When a program says its pharmacy is FDA-registered, the accurate translation is that the establishment is on FDA's register. It is not a statement about the product, about an inspection, or about approval.

When a program says its product is made in an FDA-registered facility, notice that the sentence has moved the credential from the product to the building, and that FDA has said registration does not denote approval of the establishment or its products.

Watch for the phrase FDA-approved doing quiet work nearby. FDA has flagged, as a warning sign in this specific market, a company claiming that a compounded drug is the same as an FDA-approved drug.

The useful follow-up questions are narrow. Which establishment is registered, by name and address. Whether it is a state-licensed pharmacy compounding under section 503A or a facility registered under section 503B. When it was last inspected, which is published for outsourcing facilities. A program that answers those has given you something registration alone never did.